Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)

NGM Clinical Study Site, New York

NGM Clinical Study Site, Baltimore

NGM Clinical Study Site, Richmond

NGM Clinical Study Site, Richmond

NGM Clinical Study Site, Durham

NGM Clinical Study Site, Fayetteville

NGM Clinical Study Site, Port Orange

NGM Clinical Study Site, The Villages

NGM Clinical Study Site, Boca Raton

NGM Clinical Study Site, Lakewood Rch

NGM Clinical Study Site, Sarasota

NGM Clinical Study Site, Hermitage

NGM Clinical Study Site, Germantown

NGM Clinical Study Site, Jackson

NGM Clinical Study Site, Flowood

NGM Clinical Study Site, Ann Arbor

NGM Clinical Study Site, Chicago

NGM Clinical Study Site, St Louis

NGM Clinical Study Site, Kansas City

NGM Clinical Study Site, Baton Rouge

NGM Clinical Study Site, North Little Rock

NGM Clinical Study Site, Houston

NGM Clinical Study Site, San Antonio

NGM Clinical Study Site, San Antonio

NGM Clinical Study Site 845, Edinburg

NGM Clinical Study Site, Edinburg

NGM Clinical Study Site, Austin

NGM Clinical Study Site, Chandler

NGM Clinical Study Site 814, Tucson

NGM Clinical Study Site 816, Tucson

NGM Clinical Study Site, Los Angeles

NGM Clinical Study Site, Los Angeles

NGM Clinical Study Site, Poway

NGM Clinical Study Site, La Jolla

NGM Clinical Study Site, Rialto

NGM Clinical Study Site, Fresno

NGM Clinical Study Site, San Juan